AstraZeneca Slips as Investors Look Ahead to October Results
The shares fell more than major US indexes, while Zacks consensus estimates point to lower quarterly earnings and higher revenue.
Makkler Newsroom · Sep 30, 02:28 AM · 1 min read
Market closed· · GBp · Data may be delayed
Avg. target GBp 15,968.34 (+14.2%)
Prices may be delayed and are for informational purposes only - not investment advice.
Profitability and valuation from the filed statements
Answers from price, statements, peer and news data. Not investment advice.
MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO